Methods of treating myelodysplastic syndromes using lenalidomide | Patent Number 08404717

US 08404717 B2
Application Number13070761
Publication NumberUS 20110172273 A1
Pendency2 years, 3 days
Filled DateMar 24, 2011
Priority DateOct 15, 2002
Publication DateJul 14, 2011
Expiration DateOct 15, 2022
Inventor/ApplicantsJerome B. Zeldis
ExaminesSAMALA, JAGADISHWAR RAO
Art Unit1618
Technology Center1600
Assignments
Celgene
Current
CelgeneBristol Myers Squibb
Original
Law Firm
You must be logged in to view
Login
Attorneys
Subscription-Only
View Concierge Program
Patent Prosecution report image

Empower your practice with Patexia Publication Prosecution IP Module.

Get access to our exclusive rankings and unlock powerful data.
Check our Latest ReportPurchase IP Module

Looking for a Publication Attorney?

Get in touch with our team or create your account to start exploring a network of over 120K attorneys.